Stanford University · Social ScienceCenter for Ethical Patient Engagement in Drug Development
Meghan Halley · Stanford, California
Research Focus
Dr. Meghan Halley's lab at Stanford University explores the ethical dimensions of patient engagement in drug development for rare diseases. This research addresses the critical challenges and tensions that arise when patient and family groups collaborate with academic institutions and pharmaceutical companies to advance treatment options. By involving diverse stakeholders, the lab aims to create practical strategies for navigating ethical issues that impact research outcomes and enhance public trust in drug development processes.
patient-focused drug developmentrare diseasesethicsstakeholder engagementgenomics
Research Aims
3AIM 01Explore stakeholder perspectives on ethical challenges in patient-focused drug development.
AIM 02Characterize the values and interests of key stakeholders involved in rare disease research.
AIM 03Evaluate strategies for managing identified ethical challenges through multi-stakeholder consensus.
Skills the Lab Values
semi-structured interviewsstakeholder analysisDelphi panel methodologyconsensus buildingdata analysis
Output against the department
Publications114bottom 45% of dept.42nd of 77
this lab
most publishedleast published
Citations2.0kbottom 42% of dept.45th of 77
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.